1. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis 
Kevin L. Greason, MD, Verghese Mathew, MD, Rakesh M. Suri, MD, David R. Holmes, MD, Charanjit S. Rihal, MD, Tom McAndrew, MS, Ke Xu, PhD, Michael Mack, MD, John G. Webb, MD, Augusto Pichard, MD, Mathew Williams, MD, Martin B. Leon, MD, Lars Svensson, MD, Vinod Thourani, MD, Craig R. Smith, MD 
The Annals of Thoracic Surgery 
Volume 98, Issue 1, Pages 1-8 (July 2014)
DOI: /j.athoracsur
Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
(A) Death of any cause, all patients. (B) Repeated hospitalization, all patients. (C) Death of any cause or repeated hospitalization, all patients. (D) Death of any cause or stroke, all patients (CI = confidence interval; HR = hazard ratio; SAVR = surgical aortic valve replacement; TAVR = transcatheter aortic valve replacement).
The Annals of Thoracic Surgery  , 1-8DOI: ( /j.athoracsur )
Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions